Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
-Top-line data forthcoming- SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company†or “Revelationâ€), a…